CyBio ( and Promega ( are working together to develop and market applications on CyBio’s liquid-handling instruments. CyBio maintains a cooperation with a partner who develops and distributes worldwide highly specific reagents, kits, and assays for gene, protein, and cell analysis. The goal is to jointly develop validated application protocols and to market those for high-throughput screening processes in drug development and life science research. The partnership will initially focus on the automation of Promega’s cell-based multiplex-assays using CyBio’s CyBi®-Well and CyBi®-Well vario pipettors.

Next articleUMMZ Periodical Cicada Page